Neoadjuvant chemotherapy for breast cancer in a UK cancer network.

Introduction: The indications and practice in patients with neoadjuvant chemotherapy (NAC) for breast cancer needs auditing to assess criteria and expectations with this treatment. The management of the axilla in such patients is a hot topic at present.